MoneyWorks4Me

The revenue declined to Rs. 674.50 millions for the quarter ended June 2023 as compared to Rs. 702.19 millions during the corresponding quarter last year.Net Profit of the company move down -48.38% to Rs. 54.46  millions from Rs. 105.50 millions  in the same quarter last year.Operating profit for the quarter ended June 2023 decreased to 142.04 millions as compared to 184.00 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 674.50 702.19 -3.94 674.50 702.19 -3.94 2509.95 4561.32 -44.97
Other Income 3.96 3.77 5.04 3.96 3.77 5.04 29.41 35.12 -16.26
PBIDT 142.04 184.00 -22.80 142.04 184.00 -22.80 632.29 1752.37 -63.92
Interest 21.85 12.19 79.25 21.85 12.19 79.25 60.20 29.17 106.38
PBDT 120.19 171.81 -30.04 120.19 171.81 -30.04 406.80 1723.20 -76.39
Depreciation 47.79 31.31 52.63 47.79 31.31 52.63 149.19 106.44 40.16
PBT 72.40 140.50 -48.47 72.40 140.50 -48.47 257.61 1616.76 -84.07
TAX 17.94 35.00 -48.74 17.94 35.00 -48.74 62.92 416.28 -84.89
Deferred Tax -0.29 0.00 0.00 -0.29 0.00 0.00 1.37 2.75 -50.18
PAT 54.46 105.50 -48.38 54.46 105.50 -48.38 194.69 1200.48 -83.78
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 21.06 26.20 -19.64 21.06 26.20 -19.64 25.19 38.42 -34.43
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..